<?xml version="1.0" encoding="UTF-8"?>
<AssessmentQuestion xmlns="http://soap.sforce.com/2006/04/metadata">
    <assessmentQuestionVersion>
        <isActive>true</isActive>
        <name>Lanadelumab_Renewal_RenewalCriteria_Q15</name>
        <optionSourceResponseValue>false</optionSourceResponseValue>
        <questionText>Definition: Continued response is defined as no increase in the average number of HAE attacks per month for which acute injectable treatment was received compared with the average number of attacks per month observed prior to initiating treatment with lanadelumab/berotralstat.</questionText>
        <responseValues>Yes
No</responseValues>
        <status>Active</status>
        <versionNumber>3</versionNumber>
    </assessmentQuestionVersion>
    <dataType>Radio</dataType>
    <developerName>Lanadelumab_Renewal_RenewalCriteria_Q15</developerName>
    <name>Lanadelumab_Renewal_RenewalCriteria_Q15</name>
    <questionCategory>Demographic</questionCategory>
</AssessmentQuestion>
